Unicorn Biotechnologies logo — Reclaim your weekend

Unicorn Biotechnologies

Reclaim your weekend

Founded 2020 United Kingdom Sheffield, United Kingdom 15 employees Seed Total: $3.20M Biotechnology

General Information

Company Name Unicorn Biotechnologies
Founded Year 2020
Location United Kingdom Sheffield, United Kingdom
Employees 15
Industries Biotechnology
Funding Stage Seed
Business Model B2B, Platform, SaaS
Revenue Model Product Sales, Subscription, Service Fee
Offices as of Sep 2026
Sheffield, United Kingdom
Social

BounceWatch is an independent company data service, not affiliated with Unicorn Biotechnologies. To contact Unicorn Biotechnologies, visit unicornb.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Unicorn Biotechnologies compare?

A PDF of Unicorn Biotechnologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Unicorn Biotechnologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Unicorn Biotechnologies

Unicorn Biotechnologies, founded in 2020, is a promising player in the Biotechnology industry based in the United Kingdom. Their mission, encapsulated in the slogan "Liberating scientists & scaling cell biology," focuses on reducing the burdensome manual tasks that stifle biologists.

The company has developed intelligent machines designed to streamline the workflow in biological research, effectively removing time-consuming manual labor from the equation. This innovation not only accelerates scientific research but also offers clear pathways for innovations to transition from the lab bench to industrial-scale production.

In its recent financial round, Unicorn Biotechnologies secured a $3.20M Seed Round on April 21, 2022, backed by notable investors such as SOSV, HAX, Marinya Capital, and others. This funding positions the company well for future growth and further advancement of their pioneering technologies.

Business keywords: Cell Biology, Intelligent Machines, Biomanufacturing, Cultivated Meat, Next-Generation Manufacturing, Research Acceleration, Cell-based Products, Scaling Innovations, Animal-Free Agriculture

Services & Products

Automated Cell Culture Systems
Protocol Development
Systems Integration
Bespoke Solutions for Lab Automation

Target Customers

Research Scientists Laboratory Managers Lab Automation Leads Manufacturing Directors Manufacturing Technicians

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $3.20M 8
SOSV, HAX +6
21 Apr 2022
Convertible Note Undisclosed 2
SOSV, HAX
24 Mar 2021

Unicorn Biotechnologies Alternatives & Competitors

View All Alternatives
Unicorn Biotechnologies vs
Multus
Multus United Kingdom

Better media, by design

Seed
27 employees
Agriculture, Biotechnology
Unicorn Biotechnologies vs
NouBio Inc
NouBio Inc United States

Bio-Intelligent Manufacturing To Unlock Cell-Based Foods & Therapies

Pre-Seed
4 employees
Biotechnology
Unicorn Biotechnologies vs
Hoxton Farms
Hoxton Farms United Kingdom

A new era of industrial biology.

40 employees
Biotechnology

FAQ About Unicorn Biotechnologies

Reclaim your weekend
Unicorn Biotechnologies was founded in 2020.
Unicorn Biotechnologies is headquartered in Sheffield, United Kingdom.
Unicorn Biotechnologies operates in Biotechnology. Its work centres on Cell Biology, Intelligent Machines, Biomanufacturing and Cultivated Meat. Its customers include Research Scientists, Laboratory Managers and Lab Automation Leads.
Unicorn Biotechnologies has a B2B, Platform and SaaS business model. Its revenue comes from Product Sales, Subscription and Service Fee.
Unicorn Biotechnologies has approximately 15 employees.
Unicorn Biotechnologies has completed 2 funding rounds, raising a total of $3.20M. The latest funding stage is Seed.
Unicorn Biotechnologies offers: Automated Cell Culture Systems, Protocol Development, Systems Integration, Bespoke Solutions for Lab Automation.
Top alternatives and competitors to Unicorn Biotechnologies include Multus, NouBio Inc, Hoxton Farms, Omeat, Jimi Biotech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Unicorn Biotechnologies and Multus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Unicorn Biotechnologies, https://bouncewatch.com/company/unicorn-biotechnologies, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes